Global Tumor Ablation Market 2023-2029

Tumor ablation is a minimally invasive medical procedure that is used to destroy cancer cells within tumors. This procedure involves the use of heat, cold, or chemicals to destroy cancer cells within tumors, which may be primary or metastatic. Tumor ablation is considered a minimally invasive procedure because it does not require surgery to access tumors. Instead, a small incision is made through the skin, and a special probe is inserted into the tumor to deliver the heat, cold, or chemicals used for ablation. Tumor ablation can be used in combination with other cancer treatments, such as chemotherapy or radiation therapy, to increase the effectiveness of cancer treatment. According to the latest estimates, the global tumor ablation market size is expected to increase from USD 919.0 million in 2022 to USD 1,939.5 million by 2029, garnering a CAGR of 11.26% over the evaluated period.

The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global tumor ablation market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors approaches.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the technology, treatment, application, end user, and region. The global market for tumor ablation can be segmented by technology: radiofrequency, microwave, irreversible electroporation, cryoablation, other. The radiofrequency segment was the largest contributor to the global tumor ablation market in 2022. Tumor ablation market is further segmented by treatment: surgical ablation, percutaneous ablation, laparoscopic ablation. According to the research, the surgical ablation segment had the largest share in the global tumor ablation market. Based on application, the tumor ablation market is segmented into: lung cancer, kidney cancer, liver cancer, others. The lung cancer segment held the largest revenue share in 2022. On the basis of end user, the tumor ablation market also can be divided into: hospitals and clinics, specialty centers, others. Globally, the hospitals and clinics segment made up the largest share of the tumor ablation market. Tumor ablation market by region is categorized into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America.

Market Segmentation
By technology: radiofrequency, microwave, irreversible electroporation, cryoablation, other
By treatment: surgical ablation, percutaneous ablation, laparoscopic ablation
By application: lung cancer, kidney cancer, liver cancer, others
By end user: hospitals and clinics, specialty centers, others
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America

The report also provides analysis of the key companies of the industry and their detailed company profiles including Johnson & Johnson, Medtronic plc, Boston Scientific Corporation, SonaCare Medical, LLC, EDAP TMS SA, AngioDynamics, Inc., HealthTronics, Inc., Misonix, Inc., Biotronik, Inc., among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Scope of the Report
To analyze and forecast the market size of the global tumor ablation market.
To classify and forecast the global tumor ablation market based on technology, treatment, application, end user, region.
To identify drivers and challenges for the global tumor ablation market.
To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global tumor ablation market.
To identify and analyze the profile of leading players operating in the global tumor ablation market.

Why Choose This Report
Gain a reliable outlook of the global tumor ablation market forecasts from 2023 to 2029 across scenarios.
Identify growth segments for investment.
Stay ahead of competitors through company profiles and market data.
The market estimate for ease of analysis across scenarios in Excel format.
Strategy consulting and research support for three months.
Print authentication provided for the single-user license.

PART 1. INTRODUCTION
Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
Introduction
Drivers
Restraints
PART 5. MARKET BREAKDOWN BY TECHNOLOGY
Radiofrequency
Microwave
Irreversible electroporation
Cryoablation
Other
PART 6. MARKET BREAKDOWN BY TREATMENT
Surgical ablation
Percutaneous ablation
Laparoscopic ablation
PART 7. MARKET BREAKDOWN BY APPLICATION
Lung cancer
Kidney cancer
Liver cancer
Others
PART 8. MARKET BREAKDOWN BY END USER
Hospitals and clinics
Specialty centers
Others
PART 9. MARKET BREAKDOWN BY REGION
North America
Europe
Asia-Pacific
MEA (Middle East and Africa)
Latin America
PART 10. KEY COMPANIES
Johnson & Johnson
Medtronic plc
Boston Scientific Corporation
SonaCare Medical, LLC
EDAP TMS SA
AngioDynamics, Inc.
HealthTronics, Inc.
Misonix, Inc.
Biotronik, Inc.
DISCLAIMER

Fill The Form For Sample Request

Full Name*

Business Email *

E-mail

Country *

Select Country Albania Algeria Afghanistan Angola Argentina Armenia Aruba Australia Austria Azerbaijan Andorra Anguilla Bahrain Bangladesh Barbados Belarus Belgium Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Bulgaria Burkina Faso Burundi Bosnia Cambodia Cameroon Central African Republic Chad Chile China Colombia Comoros Congo (Brazzaville) Cook Islands Costa Rica Cote d Ivoire Croatia Cuba Cyprus Czech Republic Cayman Islands Denmark Djibouti Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Fiji Finland France Gabon Gambia Georgia Germany Ghana Gibraltar Greece Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Herzegovina Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kuwait Korea Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Lithuania Luxembourg Liechtenstein Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Moldova Monaco Mongolia Montenegro Morocco Mozambique Myanmar Middle East & North Africa (MENA) Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria North Korea Norway Oman Pakistan Palau Palestinian Territories Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Palestine Qatar Romania Russia Rwanda Samoa Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Korea Spain Sri Lanka Saint Kitts and Nevis Saint Vincent and the Grenadines Sudan Suriname Swaziland Sweden Switzerland Syria Scotland San Marino Taiwan Tajikistan Tanzania Thailand Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States of America Uruguay Uzbekistan Uraguay Vanuatu Venezuela Vietnam Virgin Islands Yemen Zambia Zimbabwe Canada Grenada Cape Verde Belize Curacao Republic of Srpska Antigua and Barbuda Saint Lucia Falkland Islands Faroe Islands Federated States of Micronesia Guadeloupe Martinique Montserrat Niue

Contact No *

Alternate No

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available